Raj Sahulee1, Irene D Lytrivi2, Jill J Savla3, Joseph W Rossano3. 1. Division of Pediatric Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: raj.sahulee@mssm.edu. 2. Division of Pediatric Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York. 3. Division of Pediatric Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Abstract
BACKGROUND: In 2004, the United Network for Organ Sharing (UNOS) added the label "high-risk donor" (HRD) for any organ donor who met the Centers for Disease Control (CDC) criteria for high-risk behavior for infection. The aim of this study was to calculate the rate of HRD graft use in heart transplantation in children and determine the differences in outcome from those who received standard-risk donor (SRD) grafts. METHODS: We reviewed information from the UNOS database regarding transplants performed between June 30, 2004 and July 31, 2012. Heart transplant recipients <18 years old were divided into two groups based on the donor's risk status. Demographic data on donors and recipients were collected. Survival analysis was performed to compare survival based on donor status. We also compared episodes of rejection before hospital discharge and the length of stay after transplantation by donor status. RESULTS: During the study period, 2,782 pediatric heart transplantations were performed and 116 (4.1%) patients received a CDC HRD graft. Recipients of HRD grafts were significantly older and heavier than those who received an SRD graft (8.5 vs 6.5 years, p < 0.001 and 35.7 vs 26.9 kg, p < 0.001). There was no difference in patient survival (log rank, p = 0.88) between groups. There was no difference in rejection prior to discharge (17.2 vs 16.4%, p = 0.81) or length of stay after transplantation (26.1 vs 27.6 days, p = 0.58). CONCLUSIONS: CDC HRD graft status does not appear to significantly affect recipient outcome after heart transplantation in children.
BACKGROUND: In 2004, the United Network for Organ Sharing (UNOS) added the label "high-risk donor" (HRD) for any organ donor who met the Centers for Disease Control (CDC) criteria for high-risk behavior for infection. The aim of this study was to calculate the rate of HRD graft use in heart transplantation in children and determine the differences in outcome from those who received standard-risk donor (SRD) grafts. METHODS: We reviewed information from the UNOS database regarding transplants performed between June 30, 2004 and July 31, 2012. Heart transplant recipients <18 years old were divided into two groups based on the donor's risk status. Demographic data on donors and recipients were collected. Survival analysis was performed to compare survival based on donor status. We also compared episodes of rejection before hospital discharge and the length of stay after transplantation by donor status. RESULTS: During the study period, 2,782 pediatric heart transplantations were performed and 116 (4.1%) patients received a CDC HRD graft. Recipients of HRD grafts were significantly older and heavier than those who received an SRD graft (8.5 vs 6.5 years, p < 0.001 and 35.7 vs 26.9 kg, p < 0.001). There was no difference in patient survival (log rank, p = 0.88) between groups. There was no difference in rejection prior to discharge (17.2 vs 16.4%, p = 0.81) or length of stay after transplantation (26.1 vs 27.6 days, p = 0.58). CONCLUSIONS: CDC HRD graft status does not appear to significantly affect recipient outcome after heart transplantation in children.
Keywords:
Center for Disease Control (CDC); United Network for Organ Sharing (UNOS); high risk donor; human immunodeficiency virus (HIV); pediatric heart transplantation
Authors: Pallavi D Annambhotla; Brian M Gurbaxani; Matthew J Kuehnert; Sridhar V Basavaraju Journal: Transpl Infect Dis Date: 2017-03-27 Impact factor: 2.228
Authors: Danielle S Burstein; Joseph W Rossano; JoAnn Lindenfeld; Kelly H Schlendorf; Nhue Do; Justin Godown; Matthew J O'Connor; Katsuhide Maeda; Jonathan B Edelson; Kimberly Y Lin; Jeremy A Mazurek; Shelley R Scholl; Jonathan N Menachem Journal: JAMA Cardiol Date: 2022-09-21 Impact factor: 30.154
Authors: Christian Corbin Frye; Jason M Gauthier; Amit Bery; William D Gerull; Deniz B Morkan; Jingxia Liu; M Shea Harrison; Yuriko Terada; Judith E Van Zanden; Gary F Marklin; Michael K Pasque; Ruben G Nava; Bryan F Meyers; Alexander G Patterson; Benjamin D Kozower; Ramsey Hachem; Derek Byers; Chad Witt; Hrishikesh Kulkarni; Daniel Kreisel; Varun Puri Journal: Clin Transplant Date: 2020-12-14 Impact factor: 2.863